Survival function of clinical and radiographic success of three obturating materials in primary teeth at 3, 6 and 9 months periodic intervals - A randomized controlled clinical trial
The study aims to assess clinically and radiographically the success of zinc oxide eugenol, metapex, and endoflas as root canal obturating materials in primary teeth over 3, 6, and 9 months of time intervals. The randomized controlled trial was performed in 60 primary molars of 36 children aged betw...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
| Series: | Journal of Pharmacy and Bioallied Sciences |
| Subjects: | |
| Online Access: | http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2023;volume=15;issue=5;spage=747;epage=751;aulast=Kumar |
| _version_ | 1797645500340502528 |
|---|---|
| author | Kandaswamy Saravana Kumar Sharath Asokan P R Geethapriya Kailasam Sivakumar Andamuthu Yamunadevi |
| author_facet | Kandaswamy Saravana Kumar Sharath Asokan P R Geethapriya Kailasam Sivakumar Andamuthu Yamunadevi |
| author_sort | Kandaswamy Saravana Kumar |
| collection | DOAJ |
| description | The study aims to assess clinically and radiographically the success of zinc oxide eugenol, metapex, and endoflas as root canal obturating materials in primary teeth over 3, 6, and 9 months of time intervals. The randomized controlled trial was performed in 60 primary molars of 36 children aged between 4 and 9 years. Permanent restorations were given and stainless steel crowns were placed for the treated tooth. Comparing the survival proportion between the three groups was done using the Wilcoxon (Gehans) statistical test. The clinical survival variable showed 100% survival proportion for zinc oxide eugenol and endoflas, while for metapex it was 69% at the end of 9 months. The radiographical survival proportion was 100% for zinc oxide eugenol, followed by endoflas at 92% and 58% for metapex group. |
| first_indexed | 2024-03-11T14:47:44Z |
| format | Article |
| id | doaj.art-840176f9926a40af88cb65bfc71e7227 |
| institution | Directory Open Access Journal |
| issn | 0975-7406 |
| language | English |
| last_indexed | 2024-03-11T14:47:44Z |
| publishDate | 2023-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Journal of Pharmacy and Bioallied Sciences |
| spelling | doaj.art-840176f9926a40af88cb65bfc71e72272023-10-30T10:31:54ZengWolters Kluwer Medknow PublicationsJournal of Pharmacy and Bioallied Sciences0975-74062023-01-0115574775110.4103/jpbs.jpbs_579_22Survival function of clinical and radiographic success of three obturating materials in primary teeth at 3, 6 and 9 months periodic intervals - A randomized controlled clinical trialKandaswamy Saravana KumarSharath AsokanP R GeethapriyaKailasam SivakumarAndamuthu YamunadeviThe study aims to assess clinically and radiographically the success of zinc oxide eugenol, metapex, and endoflas as root canal obturating materials in primary teeth over 3, 6, and 9 months of time intervals. The randomized controlled trial was performed in 60 primary molars of 36 children aged between 4 and 9 years. Permanent restorations were given and stainless steel crowns were placed for the treated tooth. Comparing the survival proportion between the three groups was done using the Wilcoxon (Gehans) statistical test. The clinical survival variable showed 100% survival proportion for zinc oxide eugenol and endoflas, while for metapex it was 69% at the end of 9 months. The radiographical survival proportion was 100% for zinc oxide eugenol, followed by endoflas at 92% and 58% for metapex group.http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2023;volume=15;issue=5;spage=747;epage=751;aulast=Kumarendoflasmetapexzinc oxide eugenol |
| spellingShingle | Kandaswamy Saravana Kumar Sharath Asokan P R Geethapriya Kailasam Sivakumar Andamuthu Yamunadevi Survival function of clinical and radiographic success of three obturating materials in primary teeth at 3, 6 and 9 months periodic intervals - A randomized controlled clinical trial Journal of Pharmacy and Bioallied Sciences endoflas metapex zinc oxide eugenol |
| title | Survival function of clinical and radiographic success of three obturating materials in primary teeth at 3, 6 and 9 months periodic intervals - A randomized controlled clinical trial |
| title_full | Survival function of clinical and radiographic success of three obturating materials in primary teeth at 3, 6 and 9 months periodic intervals - A randomized controlled clinical trial |
| title_fullStr | Survival function of clinical and radiographic success of three obturating materials in primary teeth at 3, 6 and 9 months periodic intervals - A randomized controlled clinical trial |
| title_full_unstemmed | Survival function of clinical and radiographic success of three obturating materials in primary teeth at 3, 6 and 9 months periodic intervals - A randomized controlled clinical trial |
| title_short | Survival function of clinical and radiographic success of three obturating materials in primary teeth at 3, 6 and 9 months periodic intervals - A randomized controlled clinical trial |
| title_sort | survival function of clinical and radiographic success of three obturating materials in primary teeth at 3 6 and 9 months periodic intervals a randomized controlled clinical trial |
| topic | endoflas metapex zinc oxide eugenol |
| url | http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2023;volume=15;issue=5;spage=747;epage=751;aulast=Kumar |
| work_keys_str_mv | AT kandaswamysaravanakumar survivalfunctionofclinicalandradiographicsuccessofthreeobturatingmaterialsinprimaryteethat36and9monthsperiodicintervalsarandomizedcontrolledclinicaltrial AT sharathasokan survivalfunctionofclinicalandradiographicsuccessofthreeobturatingmaterialsinprimaryteethat36and9monthsperiodicintervalsarandomizedcontrolledclinicaltrial AT prgeethapriya survivalfunctionofclinicalandradiographicsuccessofthreeobturatingmaterialsinprimaryteethat36and9monthsperiodicintervalsarandomizedcontrolledclinicaltrial AT kailasamsivakumar survivalfunctionofclinicalandradiographicsuccessofthreeobturatingmaterialsinprimaryteethat36and9monthsperiodicintervalsarandomizedcontrolledclinicaltrial AT andamuthuyamunadevi survivalfunctionofclinicalandradiographicsuccessofthreeobturatingmaterialsinprimaryteethat36and9monthsperiodicintervalsarandomizedcontrolledclinicaltrial |